47 Hospitals Slashed Their Use Of Two Key Heart Drugs After Huge Price Hikes – NPR


NPR

47 Hospitals Slashed Their Use Of Two Key Heart Drugs After Huge Price Hikes
NPR
Even before media reports and a congressional hearing vilified Valeant Pharmaceuticals International for raising prices on a pair of lifesaving heart drugs, Dr. Umesh Khot knew something was very wrong. Khot is a cardiologist at the Cleveland Clinic
Steep Price Hikes Led to Drop in Use of 2 Heart Drugs at US HospitalsPhilly.com
Use of two heart medications declined after price spikeHealio
Use of Common Heart Drugs Dropped After Price HikeHealthLeaders Media

all 4 news articles »

View original article
Author:

Powered by WPeMatico